Susquehanna International Group’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-31,584
Closed -$336K 14496
2022
Q2
$292K Sell
31,584
-28,215
-47% -$231K ﹤0.01% 9633
2022
Q1
$411K Sell
59,799
-133,486
-69% -$860K ﹤0.01% 9477
2021
Q4
$1.56M Buy
193,285
+130,155
+206% +$864K ﹤0.01% 6129
2021
Q3
$388K Buy
+63,130
New +$239K ﹤0.01% 10009
2021
Q2
Sell
-13,332
Closed -$51K 13496
2021
Q1
$51K Buy
+13,332
New +$50.6K ﹤0.01% 12028
2020
Q3
Sell
-111,957
Closed -$1.15M 11335
2020
Q2
$1.15M Sell
111,957
-67,290
-38% -$682K ﹤0.01% 5590
2020
Q1
$1.79M Buy
179,247
+161,972
+938% +$1.44M ﹤0.01% 4165
2019
Q4
$131K Buy
+17,275
New +$118K ﹤0.01% 9015

Other funds holding BLU

Susquehanna International Group's BLU Position: Q3 2022 in Review

Susquehanna International Group sold out of BELLUS Health Inc. (BLU) in Q3 2022, closing a stake of 31,584 shares — an estimated $336K sold.

Susquehanna International Group first reported a position in BLU in Q4 2019 and held it in 8 quarters. The position peaked at $1.79M in Q1 2020. 116 funds tracked by Wall St. Rank hold BLU as of Q3 2022.

  • Susquehanna International Group reported no remaining BELLUS Health Inc. position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 31,584 BELLUS Health Inc. shares in Q3 2022, an estimated $336K.
  • Susquehanna International Group first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 8 quarters.
  • Susquehanna International Group's BELLUS Health Inc. position peaked at $1.79M in Q1 2020.
  • 116 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.